ATN1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.146600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.547800E-01
Normal-vs-Stage2
7.691600E-01
Normal-vs-Stage3
8.458200E-01
Normal-vs-Stage4
2.656000E-03
Stage1-vs-Stage2
6.837000E-01
Stage1-vs-Stage3
5.555800E-01
Stage1-vs-Stage4
4.453200E-01
Stage2-vs-Stage3
5.000000E-01
Stage2-vs-Stage4
1.52592000000062E-05
Stage3-vs-Stage4
2.874800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.046400E-01
Normal-vs-AfricanAmerican
8.664400E-01
Normal-vs-Asian
9.360800E-01
Caucasian-vs-AfricanAmerican
6.981200E-01
Caucasian-vs-Asian
5.955200E-01
AfricanAmerican-vs-Asian
9.886400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.673200E-01
Normal-vs-Female
7.593400E-01
Male-vs-Female
9.586200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.061000E-01
Normal-vs-Age(41-60Yrs)
5.201200E-01
Normal-vs-Age(61-80Yrs)
8.422600E-01
Normal-vs-Age(81-100Yrs)
7.329400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.418000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.532200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.576400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.451600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.439780E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.120200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.753400E-01
Normal-vs-Daily Drinker
7.879600E-01
Normal-vs-Weekly Drinker
5.764800E-01
Normal-vs-Occasional Drinker
4.093200E-01
Normal-vs-Social Drinker
1.582560E-01
Non Drinker-vs-Daily Drinker
6.115400E-01
Non Drinker-vs-Weekly Drinker
2.899000E-01
Non Drinker-vs-Occasional Drinker
8.300100E-02
Non Drinker-vs-Social Drinker
1.710030E-01
Daily Drinker-vs-Weekly Drinker
1.582590E-01
Daily Drinker-vs-Occasional Drinker
3.504100E-02
Daily Drinker-vs-Social Drinker
1.145350E-01
Weekly Drinker-vs-Occasional Drinker
6.194400E-01
Weekly Drinker-vs-Social Drinker
4.552200E-01
Occasional Drinker-vs-Social Drinker
6.609800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.437800E-02
Normal-vs-Grade 2
2.266000E-02
Normal-vs-Grade 3
7.521900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.600600E-01
Grade 1-vs-Grade 3
8.269000E-01
Grade 1-vs-Grade 4
7.437800E-02
Grade 2-vs-Grade 3
3.331800E-01
Grade 2-vs-Grade 4
2.266000E-02
Grade 3-vs-Grade 4
7.521900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.985200E-01
Normal-vs-NonDiabetic
6.790400E-01
Diabetic-vs-NonDiabetic
1.124750E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.603600E-01
Normal-vs-NoPancreatitis
7.897200E-01
Pancreatitis-vs-NoPancreatitis
3.444600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.282800E-01
Normal-vs-N1
7.637800E-01
N0-vs-N1
5.320800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.678000E-01
Normal-vs-TP53-NonMutant
2.691800E-01
TP53-Mutant-vs-TP53-NonMutant
7.052600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
